|
1
|
Karthikeyan VS, Sistla SC, Srinivasan R,
Basu D, Panicker LC, Ali SM and Rajkumar N: Metachronous multiple
primary malignant neoplasms of the stomach and the breast: Report
of two cases with review of literature. Int Surg. 99:52–55. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Fujii M, Shirai T, Asada K, Saito Y,
Hirose M and Suda T: Synchronous diffuse large B-cell lymphoma and
squamous cell lung carcinoma. Respirol Case Rep. 2:33–35. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Vose JM: Mantle cell lymphoma: 2015 update
on diagnosis, risk-stratification, and clinical management. Am J
Hematol. 90:739–745. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bernhardt EB and Jalal SI: Small cell lung
cancer. Cancer Treat Res. 170:301–322. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cheson BD, Fisher RI, Barrington SF,
Cavalli F, Schwartz LH, Zucca E, Lister TA; Alliance, Australasian
Leukaemia and Lymphoma Group and Eastern Cooperative Oncology
Group, ; et al: Recommendations for initial evaluation, staging,
and response assessment of Hodgkin and non-Hodgkin lymphoma: The
Lugano classification. J Clin Oncol. 32:3059–3068. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cheson BD: Staging and response assessment
in lymphomas: The new Lugano classification. Chin Clin Oncol.
4:52015.PubMed/NCBI
|
|
7
|
Lee TK, Myers RT, Scharyj M and Marshall
RB: Multiple primary malignant tumors (MPMT): Study of 68 autopsy
cases (1963–1980). J Am Geriatr Soc. 30:744–753. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Henne T and Schmähl D: Occurrence of
second primary malignancies in man-a second look. Cancer Treat Rev.
12:77–94. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Roy SD, Stafford JA, Scally J and
Selvachandran SN: A rare case of breast carcinoma co-existing with
axillary mantle cell lymphoma. World J Surg Oncol. 1:272003.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Travis LB, Rabkin CS, Brown LM, Allan JM,
Alter BP, Ambrosone CB, Begg CB, Caporaso N, Chanock S, DeMichele
A, et al: Cancer survivorship-genetic susceptibility and second
primary cancers: Research strategies and recommendations. J Natl
Cancer Inst. 98:15–25. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Park SL, Caberto CP, Lin Y, Goodloe RJ,
Dumitrescu L, Love SA, Matise TC, Hindorff LA, Fowke JH, Schumacher
FR, et al: Association of cancer susceptibility variants with risk
of multiple primary cancers: the population architecture using
genomics and epidemiology study. Cancer Epidemiol Biomarkers Prev.
23:2568–2578. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chien SH, Liu CJ, Hong YC, Teng CJ, Hu YW,
Ku FC, Yeh CM, Chiou TJ, Gau JP and Tzeng CH: Development of second
primary malignancy in patients with non- Hodgkin lymphoma: A
nationwide population-based study. J Cancer Res Clin Oncol.
141:1995–2004. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kim YJ, Shin HJ, Won CH, Chang SE, Lee MW,
Choi JH and Lee WJ: The incidence of other primary cancers in
patients with cutaneous lymphoma. Ann Dermatol. 30:335–341. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Alakeel F, Lee E, Baird-Howell M and
Easley S: Synchronous ductal carcinoma in situ and intravascular
large B-cell lymphoma of the breast. Appl Immunohistochem Mol
Morphol. 27:e91–e92. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li J, Zhou C, Liu W, Sun X and Meng X:
Synchronous diffuse large B cell lymphoma of the stomach and small
cell lung carcinoma: A case report. Medicine (Baltimore).
96:e88732017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bermejo JL, Pukkala E, Johannesen TB,
Sundquist J and Hemminki K: Age time risk patterns of solid cancers
in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and
Sweden. Br J Haematol. 164:675–683. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ibrahim EM, Kazkaz GA, Abouelkhair KM,
Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, Bayer AM and Elmasri OA:
Increased risk of second lung cancer in Hodgkin's lymphoma
survivors: A meta-analysis. Lung. 191:117–134. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kampalath B, Abed N, Chitambar CR,
Vantuinen P, Chakrabarty G, Hanson G, Rao RN, Shidham VB and Chang
CC: Mantle cell lymphoma in lymph nodes with metastatic small cell
carcinoma of lung: A diagnostic and treatment dilemma. Leuk
Lymphoma. 45:409–414. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Argiris A and Murren JR: Staging and
clinical prognostic factors for small-cell lung cancer. Cancer J.
7:437–447. 2001.PubMed/NCBI
|
|
20
|
Loscocco GG, Piccini M, Bencini S and
Vergoni F: Bone marrow involvement in small cell lung cancer.
Hematol Transfus Cell Ther. 43:543–544. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pasini F, Cetto GL and Pelosi G: Does bone
marrow involvement affect prognosis in small-cell lung cancer? Ann
Oncol. 9:247–250. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brennan P, Scélo G, Hemminki K,
Mellemkjaer L, Tracey E, Andersen A, Brewster DH, Pukkala E,
McBride ML, Kliewer EV, et al: Second primary cancers among 109 000
cases of non-Hodgkin's lymphoma. Br J Cancer. 93:159–166. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fonseca D, Musthyala B, Ahmed F, Murthy SS
and Raju KVVN: A tale of synchronous lung carcinoma and diffuse
large B-cell lymphoma of ileum:a rare combination. Lung India.
32:398–401. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tokuchi Y, Kamachi M, Harada M, Hasegawa
M, Mishina T, Yamashiro K, Suzuki H and Isobe H: Synchronous triple
lung cancers after treatment for non-Hodgkin's
lymphoma:metachronous quadruple cancers. Intern Med. 42:1031–1034.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
André M, Mounier N, Leleu X, Sonet A,
Brice P, Henry-Amar M, Tilly H, Coiffier B, Bosly A, Morel P, et
al: Second cancers and late toxicities after treatment of
aggressive non-Hodgkin lymphoma with the ACVBP regimen: A GELA
cohort study on 2837 patients. Blood. 103:1222–1228. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Moser EC, Noordijk EM, van Leeuwen FE,
Baars JW, Thomas J, Carde P, Meerwaldt JH, van Glabbeke M and
Kluin-Nelemans HC: Risk of second cancer after treatment of
aggressive non-Hodgkin's lymphoma;an EORTC cohort study.
Haematologica. 91:1481–1488. 2006.PubMed/NCBI
|
|
27
|
Smeland KB, Kiserud CE, Lauritzsen GF,
Blystad AK, Fagerli UM, Falk RS, Fluge O, Fosså A, Kolstad A, Loge
JH, et al: A national study on conditional survival, excess
mortality and second cancer after high dose therapy with autologous
stem cell transplantation for non-Hodgkin lymphoma. Br J Haematol.
173:432–443. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Mersheimer WL, Ringel A and Eisenberg H:
Some characteristics of multiple primary cancers. Ann NY Acad Sci.
114:896–921. 1964. View Article : Google Scholar
|
|
29
|
Cybulski C, Nazarali S and Narod SA:
Multiple primary cancers as a guide to heritability. Int J Cancer.
135:1756–1763. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rivera B, Castellsagué E, Bah I, van
Kempen LC and Foulkes WD: Biallelic NTHL1 mutations in a woman with
multiple primary tumors. N Engl J Med. 373:1985–1986. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Luo YH, Ho HL, Tsai CM, Shih JF, Chiu CH,
Lai SL, Lee YC, Perng RP, Whang-Peng J, Chou TY and Chen YM: The
association between tumor epidermal growth factor receptor (EGFR)
mutation and multiple primary malignancies in patients with
adenocarcinoma of the lungs. Am J Clin Oncol. 38:147–151. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Aqeel M, Uysal-Biggs N, Fenske TS and Rao
N: one pulmonary lesion, 2 synchronous malignancies. J Investig Med
High Impact Case Rep. 6:23247096187859342018.PubMed/NCBI
|
|
33
|
Hatzibougias D, Bobos M, Karayannopoulou
G, Karkavelas G, Karapanagiotidis GT, Foroulis CN and Kostopoulos
I: A rare tumoral combination, synchronous lung adenocarcinoma and
mantle cell lymphoma of the pleura. World J Surg Oncol. 6:1372008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kai K, Ryu Y, Kamochi K, Nishioka A,
Kubota Y, Nakamura M, Kimura S, Sueoka E and Aishima S: Synchronous
mantle cell lymphoma and lung adenocarcinoma presenting in a
pleural effusion: A rare tumor combination and a potential pitfall
of cytodiagnosis. Cytopathology. 29:400–402. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Samuel G, Simoff M, Chaabaan S and
Diaz-Mendoza J: Synchronic diagnosis of non-hodgkin lymphoma and
lung adenocarcinoma via EBUS-guided TBNA. J Bronchology Interv
Pulmonol. 25:e41–e42. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Braham E, Zarrouk M, Mlika M, Kilani T and
El Mezni F: Synchronous mantle cell lymph node lymphoma and
pulmonary adenocarcinoma: A case report with literature review.
Clin Respir J. 11:430–432. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Craig FE and Foon KA: Flow cytometric
immunophenotyping for hematologic neoplasms. Blood. 111:3941–3967.
2008. View Article : Google Scholar : PubMed/NCBI
|
